AzTrials
AzTrials

Breech PresentationDISCOURS-SIEGENCT07314970

Discourse on the Mother's Decision Regarding the Mode of Delivery in Cases of Breech Presentation

An observational study of Breech Presentation, run by University Hospital, Strasbourg, France at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Breech presentation is a common occurrence in routine practice, occurring in 3-4% of all term pregnancies. Despite its frequency, breech presentation at term remains a subject of considerable controversy within the medical community. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Breech Presentation
What is being tested?
To complete a questionnaire
How many people
200 participants
Where
1 siteFrance
Study dates
28 Jan 2025to Feb 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: * Doctor with a medical degree (Junior Doctor, Clinical Assistant, Hospital Practitioner, University Professor of Obstetrics), with a primary focus on Obstetrics. * Patient of legal age (≥ 18 years) * Having given birth in 2024 in a university hospital in the Grand-Est region (Besançon, Reims, Strasbourg, Nancy)

Who may be able to join

  • Regarding practitioners:
  • Doctor with a medical degree (Junior Doctor, Clinical Assistant, Hospital Practitioner, University Professor of Obstetrics), with a primary focus on Obstetrics
  • Practicing in a University Hospital in the Grand Est region (Besançon, Reims, Strasbourg, Nancy)
  • Agreeing to complete the self-administered questionnaire anonymously.
  • Regarding patients:
  • Patient of legal age (≥ 18 years)
Show all 9Show fewer
  • Having given birth in 2024 in a university hospital in the Grand-Est region (Besançon, Reims, Strasbourg, Nancy)
  • Delivery of a breech fetus > 37 weeks of gestation
  • Agreeing to answer the self-administered questionnaire anonymously.

Who cannot join

  • Regarding practitioners:
  • Other primary activity than obstetrics
  • Regarding patients:
  • Minor patient at the time of delivery
  • Patient who had a cesarean section due to a uterine scar and maternal desire.
  • Patients with a history of uterine scarring or the presence of obstruction previa were also excluded due to the impossibility of authorizing vaginal delivery, regardless of fetal presentation.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

France1 site, 1 recruiting
  • Service de Gynécologique et d'Obstétrique - CHU de Strasbourg - France

    Strasbourg, 67091

    Mary PONTVIANNE, MD, 33 3 88 12 75 07, mary.pontvianne@chru-strasbourg.fr

    Mary PONTVIANNE, MD

    Recruiting

Other trials in France

About this study

Official title: Impact of the Practitioner's Discourse on the Mother's Decision Regarding the Mode of Delivery in Cases of Breech Presentation

Breech presentation is a common occurrence in routine practice, occurring in 3-4% of all term pregnancies. Despite its frequency, breech presentation at term remains a subject of considerable controversy within the medical community. This results in differing management approaches depending on the country, the center, and the practitioner. Indeed, from a pathophysiological perspective, during a breech delivery, the fetal head is the last segment to descend into the maternal pelvis. This is the largest fetal segment in terms of volume. Furthermore, the fetal head cannot accommodate itself to the maternal pelvis through plastic deformation. This presentation can therefore lead to specific complications that may be life-threatening for the unborn child.

Despite its frequency, breech presentation at term remains a subject of considerable controversy within the medical community regarding the management of labor. In the 2000s, a randomized trial called the TERM BREECH TRIAL found a neonatal benefit of planned cesarean section compared to vaginal delivery of a breech fetus (prevention of perinatal death in 1% of cases). This resulted in a significant increase in the rate of planned cesarean sections for breech presentation worldwide. However, numerous more recent studies (notably PREMODA in France) have highlighted the many biases of the Term Breech Trial, and various literature reviews (including the 2015 Cochrane review) have demonstrated lower perinatal morbidity than that found by Hannah's team. In 2020, the CNGOF (National College of Gynecologists and Obstetricians of France) published new recommendations on the management of breech presentations at the end of pregnancy, proposing vaginal delivery as a possible alternative to a planned cesarean section, provided that the patient receives clear and honest information (benefits and risks of each delivery method). The choice of delivery method must be made in consultation with the patient after a dedicated consultation. Since these recommendations were published, management practices still vary between hospitals despite fairly precise guidelines.

Being tested
To complete a questionnaire
Keywords
Breech Presentation
Medical subject headings
Breech Presentation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • To complete a questionnaireOther

    Doctor and Adult woman agreeing to complete the self-administered questionnaire anonymously.

Study groups in NCT07314970
Study groupRoleWhat they receive
Doctor with a primary focus on Obstetrics* Practicing in a University Hospital in the Grand Est region (Besançon, Reims, Strasbourg, Nancy) * Agreeing to complete the self-administered questionnaire anonymously.
Receives: Other: To complete a questionnaire
Adult woman (≥ 18 years old)* Gave birth in 2024 at a university hospital in the Grand Est region (Besançon, Reims, Strasbourg, Nancy) * Breech delivery > 37 weeks gestation * Agree to complete the self-administered questionnaire anonymously.
Receives: Other: To complete a questionnaire

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Overall satisfaction of women who gave birth to a breech fetus regarding their medical care

    Questionnaire from the book "The Joyful and Relaxed Pregnancy Guide"

    Score from 0 to 10:

    0 = Not at all satisfied 5 = Partially satisfied 10 = Completely satisfied

    Measured: Up to 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Jan 2026
  2. Study start28 Jan 2025
  3. Primary completionFeb 2026 (estimated)
  4. Study completionFeb 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Retrospective
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07314970
Sponsor's protocol ID
9537
Acronym
DISCOURS-SIEGE
Status last verified
Dec 2025
First submitted
17 Dec 2025
Last updated
2 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Breech Presentation, run by University Hospital, Strasbourg, France at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 2 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Mary PONTVIANNE, MD (33 3 88 12 75 07, mary.pontvianne@chru-strasbourg.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Overall satisfaction of women who gave birth to a breech fetus regarding their medical care (time frame: Up to 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in